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Jacobson and Herzenberg (1)  and Jacobson et  al.  (2)  have  shown  that  (SJL  X 
BALB/c)F1 mice  exposed to  antibody to  an  immunoglobulin allotype early in  life 
often develop a  chronic suppression of production of that allotype. The key finding 
that transfer of a syngeneic mixture of chronically suppressed and normal spleen cells 
into an irradiated host results in suppression showed that chronically suppressed mice 
have cells that actively suppress the allotype  production. 
Thus,  when  SJL males  (Ig  b)  are mated to BALB/c females  (Ig  ~)  previously im- 
munized to Ig-lb (the allotype on IgG2a globulins), many of the progeny are actively 
suppressed for Ig-lb. This suppression is most clearly manifest in mice over the age of 
6 too, when about half the mice are chronically suppressed, i.e., consistently show no 
detectable Ig-lb in circulation. Before 6 too, about 95% of the exposed mice synthesize 
some Ig-lb, although the levels often fluctuate in a range considerably below normal. 
In the studies in which Jacobson et al. (2) demonstrated the existence of the actively 
suppressing  cell population,  spleen  cells  from  chronically suppressed  donors  were 
mixed with spleen cells from normal syngeneic donors (i.e. BALB/c  X  SJL hybrids 
not  exposed to  anti-Ig-lb) and  transferred  to  irradiated (600  R)  BALB/c mice  in 
which  production  of Ig-lb could be followed by measuring  serum  levels of Ig-lb. 
Transfer of normal spleen cells alone into such recipients resulted in establishment of 
Ig-lb synthesis by the  1st wk after  transfer  and  the  maintenance  of  serum  levels 
50-100-fold greater than the minimum detectable level for the duration of the experi- 
ment (greater than 6 mo in some cases). Transfer of the mixture of suppressed and 
normal cells (or of suppressed cells alone), however, was followed by only a transitory 
burst of Ig-lb synthesis after which the serum levels fell more or less rapidly depending 
on the number of suppressed cells in the mixture. 
Jacobson et al. also presented data indicating that the suppressor population 
was present in  lymphoid tissue other  than  spleen since Ig-lb synthesis in  re- 
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cipients of bone marrow from suppressed animals was suppressed,  although the 
suppression appeared  to be less marked.  We have extended this work using the 
mixture-transfer  system  and  present  data  in  this  publication  showing  that 
suppressor  cells  are  found  in  all  lymphoid  tissues  and  are  thymus  derived 
(T  cells).  We  further  show  that  suppressor  cells  are  active  in  vitro  and  sup- 
press  the  development  of  specific  antibody-forming  cells  of  the  suppressed 
allotype in Mishell-Dutton  (3)  cultures. 
Materials  al~d Methods 
Mice.--The mice used in suppression studies were derived from matings between SJL/J 
male and BALB/CN  females immunized against the paternal Ig-lb allotype  (1).  All sup- 
pressed mice were  tested by Ouchterlony for Ig-lb before use in tissue culture or  transfer 
studies. Only those with  <0.01 mg of Ig-lb/ml serum (Ouchterlony negative) were used. 
Sheep erythrocyte (SRBC)I-primed mice used in tissue culture studies were injected intra- 
peritoneally (i.p.)  with 0.1 mI of a 20% suspension of sheep erythrocytes 3-9 mo before sac- 
rifice. 
Antlsera.--Antiallotype  antisera were prepared as previously described  (4-6). Antiserum 
reacting with Ig  a (BALB/c) was prepared in SJL or LP/J mice and reacts with Ig-la (IgG2a) 
and  Ig4a  (IgG1).  Antiserum reacting with Ig  b  (SJL allotypes) plaque-forming cells  (PFC) 
was prepared in BALB/c or C3H-SW mice and reacts with Ig-lb (IgG2a) and Ig-4b (IgG1). 
Antiserum specific for Ig-lb was prepared in BALB/c mice immunized by the "H-2"  methods. 
Anti-Thy-lb antiserum  (antl-0)  was  produced  by immunizing AKR/J mice  with  C3H 
thymus according to the method of Reif and Allen (7). It is designated anti-Thy-lb according 
to the recommendation of the Committee on Standardized Genetics Nomenclature for Mice 
(8).  In most experiments presented, the anti-Thy-lb was an AKR anti-C3H  thymus; how- 
ever, in some experiments (indicated in the text) the anti-Thy-lb was prepared by immuniza- 
tion between a pair of Thy-1 congenic strains (kindly provided by Dr. E. A. Boyse). 
Complement.--For in vitro treatment of cells with anti-Thy-lb a pool of serum from young 
guinea pigs (GPS) was used as a source of complement. Immediately before use, the GPS was 
absorbed with agarose (80 mg/ml) for 1 h at 4°C to reduce its cytotoxicity for mouse cells (9). 
For development of PFC, pools of fresh GPS, absorbed twice (each time for 10 rain at 4°C) 
with sheep erythrocytes, were used at 1 : I0. 
Cell Viability.--Cell  viability was estimated by trypan blue exclusion. 
Estimation of Immunoglobulin Allotype Levds in Serum.--Levels  were estimated by radio- 
immune assay as previously described (4, 6) or by quantitative immunodiffusion with specific 
antiallotype antlsera. Estimation by the latter technique is indicated in legends for tables and 
figures. 
Assay for PFC.--A modification  (3)  of the technique described by Jerne et al.  (10)  was 
employed for the assay of hemolytic PFC. Duplicate slides were done for each point and the 
values averaged. 
To facilitate counting of indirect PFC, the formation of direct PFC was inhibited by incu- 
bation of slides with concanavalin A  (0.3  mg/ml)  for  1 h  at  37°C  before  incubation with 
developing antisera, i.e., antiallotype or rabbit antimouse IgG (11).  Control slides incubated 
with concanavalin A but not with developing antisera were done for each culture. In general, 
PFC  formation on these slides was completely inhibited; however, if any "break through" 
PFC were found, their number was subtracted from the count for indirect PFC on the slides 
incubated with developing antisera. 
1Abbreviations  used in  Ibis paper: BSS,  balanced salt solution;  FCS,  fetal  calf  serum; 
GPS,  guinea  pig  normal  serum;  PFC,  plaque-forming  cells;  SRBC,  sheep  erythrocytes; 
Thy-lb, previously referred to as AKR anti-0 C3H. tIERZENBERG,  CtIAN,  RAVITCtI,  RIBLE%  AND  HERZENBERG  1313 
Spleen Cell Culture.--Spleen cells were cultured according to cell culture methods described 
by Mishell and Dutton (3). The immunizing dose of antigen per culture dish was 30/zl of a 
0.05% SRBC suspension. Cells were harvested and assayed for PFC on day 5 of culture. Each 
culture dish was inoculated with a total of 2 X  107 viable nucleated cells. 
Removal of T Cells from Cell Suspensions by Treatment with Anti-Thy-lb  Antiserum.--For 
cell culture,  single-cell suspensions at a final cell concentration of 1 X  107 nucleated cells per 
ml were incubated with anti-Thy-lb (1:40)  and GPS (1:10)  in 5% fetal calf serum (FCS)  in 
balanced salt solution (BSS) for 45 rain at 37°C. The cells were then washed in a large volume 
of 5% FCS-BSS, resuspended in tissue culture medium, and counted, and the cell concen- 
tration was adjusted to 1.5-2  X  107 viable cells/ml. Control cell suspensions were incubated 
with GPS alone without anti-Thy-lb and treated similarly.  For in vivo transfer experiments, 
anti-Thy-lb treatment was carried out as previously described (12). 
RESULTS 
As the data in Fig. 1 show, the ability of spleen cells from normal (BALB X 
SJL)F1 mice to sustain production of Ig-lb over a period of weeks after transfer 
into irradiated  (600  R)  BALB/c mice is suppressed  when spleen  cells  from 
genetically identical "chronically" suppressed mice are mixed with the normal 
cells before transfer. Serum Ig-lb levels in recipients of 107 normal cells reach 
maximum by the 2nd wk after transfer and then are maintained at slightly 
under that level for the duration of the experiment. Ig-lb levels in recipients of 
the same number of spleen cells (107) from suppressed F1 donors climb for the 
1st 2 wk but then fall rapidly to below the margin of detectability by the 5th 
or 6th wk after transfer. Ig-lb levels in serum of recipients of 107 cells from 
normal spleens plus 107 cells from suppressed spleens (mixed before transfer) 
also climb and fall and are, in fact, indistinguishable from levels in recipients 
of  suppressed  spleen  alone. 
This data, which is similar to that previously presented (2)  except that the 
ratio of suppressed to normal cells  transferred is 1:1  instead of 1:4, indicate 
that suppressed spleen carries a transferable population of cells capable of sup- 
pressing  production  of  Ig-lb  by  normal  cells,  i.e.,  by  cells  not  previously 
exposed to anti Ig-lb antiserum. 
The data in Fig. 2 show that the suppressor activity of spleen cells from sup- 
pressed animals is destroyed by incubation of the cell suspension with antibody 
to the Thy-lb antigen, (AKR anti-C3H thymus) plus complement, a procedure 
that selectively kills thymus-derived (T) cells. Ig-lb levels in suppression con- 
trols, that is in recipients of 107 normal spleen cells transferred with 107 sup- 
pressed  spleen cells  previously incubated with nonimmune AKR serum  and 
complement, rise to 0.12 mg/ml at wk 2 and then fall rapidly to below detect- 
ability, as do levels in recipients of nontreated cells in the experiment reported 
in Fig. 1. In contrast, Ig-lb levels in recipients of 107 normal spleen cells trans- 
ferred with  107  spleen cells  preincubated with anti-Thy-lb plus complement 
appear if anything to be higher than Ig-lb levels in recipients of 107 normal 
spleen cells transferred alone. Thus, the ability of spleen cell suspensions from 
chronically suppressed animals to suppress Ig-lb production is dependent on 1314  SUPPRESSION  OF  IMMITNOGLOBULIN ALLOTYPE  SYNTItESIS.  III 
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FIG. 1.  MLxture-transfer assay for suppression  of allotype production. Lethally irradiated 
(600  R)  BALB/c mice  (Ig  ~)  were restored  with  (SJL  X  BALB/c)F1  hybrid  spleen  cells 
approximately  18  h  after irradiation.  (O)  received  107  spleen  cells  from normal  hybrids; 
([2) received 107 spleen cells from chronically suppressed  hybrids; and (A) received a mixture 
containing 107 spleen cells from suppressed hybrids plus 107 spleen cells from normal hybrids. 
Day 0 =  day of transfer. Ig-lb levels were estimated on weekly bleeds by radioimmune assay. 
Each point is the average of determinations from five mice. 
the presence of a population of cells carrying Thy-lb antigen, i.e., a population 
of T  cells. 
Some question has been raised with regard to the specificity of anti-Thy-lb 
sera  prepared by immunizing  AKR  mice  with  Thy-lb on  thymocytes from 
C3H mice. The pool of antiserum used here has been used for several studies in 
this laboratory (12). In all cases, those cells necessary for the immune response 
that were removed by treatment of a cell population with the antiserum plus 
complement were completely replaceable by thymocytes. Comparative fluores- 
cence  staining  studies  with  congenic  anti-Thy-lb  and  a  rabbit  antiserum 
specific for T  cells showed no differences between the three sera with respect to 
the number of spleen cells stained,  again demonstrating the specificity of the 
AKR  anti-C3H  Thy-lb  serum  for  T  cells  (unpublished  observations,  T. HERZENBERG~ CHAN~ RAVITCH~ RIBLET, AND HERZENBERG  ]3~5 
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FIG. 2.  Depletion of suppressor T cells from spleen by treatment with anti-Thy-lb (anti- 
0). Experimental details were the same as described in the legend for Fig. 1. (©) received 10  7 
spleen cells from normal (SJL X BALB/e)F1 hybrids;  (v1) and (A) received a mixture of 10  7 
spleen cells from normal hybrids plus 10  7 spleen cells from suppressed hybrids. Cells from sup- 
pressed hybrids were treated  with anti-Thy-lb plus complement  (A) or with AKR normal 
serum plus complement (v]) as described in legend for Table V. 
Masuda).  As a  final  check on specificity however,  some key experiments  (de- 
scribed  below)  were  repeated  with  anti-Thy-lb  made  with  a  congenic pair. 
(This serum was generously provided by Dr. E. A. Boyse.) 
In  Vilro Assay for Suppressor  T  Cells.--Similar results identifying a  T  cell 
in spleens from suppressed  animals as responsible for suppressor activity were 
obtained using a  Mishell-Dutton-type  in vitro culture  system  (3),  where  the 
ability of cultured spleen cells from normal sheep erythrocyte (SRBC)-primed 
donors  to  make  indirect  PFC  developable  by anti-Ig-lb  was  specifically in- 
hibited by the addition to the culture of unprimed spleen cells from suppressed 
animals. 
In the  experiments  presented  in Tables I  and II, spleen  cells from normal 
(BALB/c  X  SJL)F1 animals  primed 3-9 mo previously with  2  X  10  8 SRBC 
i.p.  were  cultured  with  spleen  cells  from unprimed  normal  or unprimed  sup- 
pressed mice, in the presence of 2 X  l0  t SRBC. At day 5 of culture, cells were 1316  SUPPRESSION  Ot  ~  IMMUNOGLOBULIN  ALLOTYPE  SYNTHESIS.  III 
TABLE  I 
Active Suppression  of lke Ig-lb Secondary  Response  to SRBC in C~dture 
nos. of spleen cells cultured  (X 106)  Allotype-developed plaques 
per 106 recovered cells  a/b 
Unprimed  normalized  SRBC primed 
Normal  Normal  Suppressed  a  b  a/b 
20  --  --  908  658  1.4  1 
15  5  --  716  343  2.1  1.5 
15  --  5  905  83  11  7.7 
10  10  --  286  139  2.0  1.5 
10  --  10  279  9  31  22 
Donors of all cells were  (SJL  X  BALB/c)F1  mice 6-12  mo old.  Suppressed donors were 
exposed  to  maternal anti-Ig-lb  perinatally.  The a/b  ratios  were normalized  by setting the 
ratio for primed cells alone equal to 1. 
TABLE  II 
Requirement for T Cdls for A ctire Suppression  in Culture 
nos. of spleen cells cultured  (X 10s) 
Unprimed 
SRBC primed 
Normal  Normal  Suppressed 
Treatment of 
suppressed cells 
Normalized a/b allotype ratio of PFC 
Exp. no. 
7  8  9  10 
20  None  1(2.9)  1(1.4)  1(2.3)  1(1.7) 
10  -  I0  None  6.3  22  5  15 
10  --  I0  C'  4.7  18  5.9  5.4 
10  10  C' -ff anti-Thy-lb  0.67  1.2  1.8  0.77 
10  10  --  None  0.67  1.5  1  1.4 
Donors of all  cells were  (SJL  X  BALB/c)F1  mice 6-12 mo old.  Suppressed donors were 
exposed to maternal anti-Ig-lb perinatally. Where indicated under "Treatment," cell suspen- 
sions from suppressed donors were incubated with guinea pig serum and AKR anti-Thy-lb 
or guinea pig serum alone, 37°C for 45  rain, sedimented, washed, counted, mixed with primed 
normal  cells,  and  cultured.  Results with  AKR  anti-Thy-lb were  confirmed  with  congenic 
anti-Thy-lb  in  another  experiment.  The  a/b  ratios  were  normalized  for  each  experiment 
by setting the a/b ratio for primed cells alone equal to 1 (see Table I). Total  b  PFC  per 106 
recovered  cells for each  experiment: no.  7  =  408, no. 8  =  658, no. 9  =  278, no.  10  =  77. 
plated  on  SRBC  and  the  number  of  indirect  PFC,  developed  with  several 
anti-immunoglobulin  antisera,  as  well  as  the  number  of  direct  PFC  were 
counted. 
To  simplify  the  tables,  we  have  presented  data  here  only  for  indirect  PFC 
developed  with  antiallotype  reagents.  Data  for  direct  and  total  indirect  PFC 
formation,  and  controls  relevant  to  these figures, were consistent  with  the allo- HERZENBERG, CHAN, RAVITCH, RIBLET, AND ItERZENBERG  1317 
type data.  A  manuscript describing these and related studies of in vitro sup- 
pression in greater detail is in preparation3 
As the data in Table I  show, the number of PFC developed with anti-b allo- 
type is  sharply decreased  when  the  primed  normal  cells  are  incubated  with 
unprimed  suppressed  cells.  Whereas  incubation  of  107  primed  normal  cells 
with  107 unprimed normal cells gives 139  "b" PFC/106  recovered cells,  incu- 
bation of the same number of primed cells with  107 unprimed suppressed cells 
gives only 9 "b" PFC/106 recovered cells. 
Keeping the total number of cells per culture dish  the same (2  X  107) but 
increasing the number of primed cells added to 1.5  X  107 gave proportionately 
more PFC,  but again  the cultures with unprimed  suppressed cells  (5  X  106) 
showed substantially fewer Ig-lb PFC,  83,  than cultures with a  similar num- 
ber of unprimed normal cells, 343. 3 
To allow comparison of cultures with different ratios of primed and unprimed 
cells within  a  given experiment, we calculated  the ratio of "a" allotype PFC 
to "b" allotype PFC from the data presented above. With the addition of un- 
primed normal cells, this ratio was the same whether there were equal numbers 
of primed and unprimed or three times as many primed as unprimed, i.e., 2.0 
for the former and 2.1 for the latter. With the addition of unprimed suppressor 
cells,  however,  the  ratio went up  to 33  for equal  numbers of unprimed  sup- 
pressed  and  primed  normal  and  to  11  for  1:3  unprimed  suppressed  to 
primed  normal.  The  increase  in  ratio  of  "a"  allotype  PFC  to  "b"  allotype 
PFC is a direct reflection of the decrease in "b" allotype PFC since in all cases 
the number of "a" allotype PFC remained essentially constant (see Table I). 
To determine whether the cells that suppress in culture are Thy-lb positive, 
hence  T  cells,  spleen  cell  suspensions were incubated  with  anti-Thy-lb  anti- 
serum  (AKR  anti-C3H  Thy-lb)  and  guinea pig complement,  washed,  resus- 
pended,  and added  to primed normal cells as above. Data from four such ex- 
periments are summarized in Table II. The a/b ratios in each experiment were 
normalized  to  the  ratio for 2  X  107  primed  cells cultured  alone  in  order  to 
facilitate comparison between experiments. The ratio to which each is normal- 
ized is given in parentheses on the first line. The b  PFC  from 2 X  107 primed 
cells cultured alone for each experiment is given in the legend. 
Culture of equal numbers of primed normal plus either unprimed suppressed 
or  unprimed  suppressed  treated  with  AKR  normal  serum  and  complement 
show roughly the same high a/b ratio, indicative of suppression of Ig-lb PFC. 
In  contrast,  culture  of  primed  normal  alone,  primed  normal  plus  unprimed 
normal, or primed normal plus unprimed suppressed treated with AKR  anti- 
2 Chan, E., L. A. Herzenberg, and R. I. Mishell. Personal communication. 
3 Since these experiments were done, we have shown that the serum used to develop "b" 
allotypes PFC can develop Ig-4b (IgG1) as well as Ig-lb (IgG2a) PFC, suggesting that con- 
trary to in vivo data, active suppression in vitro may be effective  against allotypes on both of 
these classes. This fascinating possibility is currently under study. 1318  SUPPRESSION  OF  IMMUNOGLOBULIN  ALLOTYPE  SYNTHESIS.  III 
C3H ThyAb all show low a/b ratios, showing that the anti-Thy-lb treatment 
has removed suppressor activity from the suppressed spleen population. These 
experiments have been repeated with congenic anti-Thy-lb. The data will be 
presented elsewhere2 
Distribution  of Suppressor T  Cell in Lymphoid Tissues.--To  assay for cell- 
associated  suppressor  activity in  various  lymphoid  organs,  106  and  107  cells 
from each of the tissues were mixed with 107 spleen cells from normal  animals 
and transferred into irradiated (600 R) BALB/c mice (in vivo mixture-transfer 
assay). As the data in Table III show, both thymus and lymph nodes from sup- 
TABLE III 
Suppressor Calls in Lymphoid Tissues 
Normal  Suppressed  donor  Ig-lb levels 
donor  no.  of 
no. of  no. of  recip-  wk after transfer 
spleen  Tissue  ceils trans-  ients 
cells  ferred  I  2  3  4  6  8 
mg/ml 
107  ND*  ND*  3  0.24  >0.38  >0.5  >0.5  >0.5  >0.5 
107  Spleen  107  4  <0.04  ..... 
107  "  106  4  0.4  0.13  <0.03  --  <0.02  0.04 
107  Thymus  107  4  0.02  ..... 
107  108  4  >0.3  >0.3  >0.32  0.12  0.15  0.08 
107  Lymph node  107  4  0.03  ..... 
107  "  "  106  4  0.4  0.11  0.08  <0.03  <0.02  -- 
Donors of all ceils were (SJL X  BALB/c)Ft mice 6-12 mo old. Suppressed donors were exposed  to materna  l 
anti-Ig-lb perinatally.  Ig lb levels were determined by immunodiffusion.  Minus signs (-)  =  <0.01 mg of Ig-lb/ 
ml. Recipients were BAI,  B/e mice irradiated with 600 R~  18 h before  transfer. 
* ND, not  done. 
pressed  animals  contain  roughly  the  same  suppressor  activity  as  spleen  at 
either cell concentration,  thymus being just somewhat less active at  10  6 cells 
transferred. Normal tissue showed no suppressor activity. 
Similar results were obtained with bone marrow as the source of suppressor 
cells.  In the  experiment presented in Table IV, 5  X  l0  t  or  10  7 bone marrow 
cells from suppressed  animals were able  to  suppress  as well,  respectively, as 
3 X  10  6 or 10  7 spleen cells.  Normal bone marrow (I(F) cells did not suppress at 
all. 
Since  bone marrow is  expected  to  contain  very few Thy-lb-positive cells, 
the sensitivity to anti-Thy-lb serum of the suppressor cell population in bone 
marrow was tested. As the data in Table V  show, suppressor activity was lost 
after exposure of the cells to AKR anti-C3H Thy-lb plus complement but not 
exposure to AKR normal  sermn  plus  complement, indicating  that just as in 
the spleen,  the Thy-lb-positive population in bone marrow contains  the cells 
responsible  for  suppression.  The  results  for  treatment  of  suppressed  bone 
marrow with congenic anti-Thy-lb were similar {see Table V). 
If  a  generous  estimate  of  10%  Thy-lb-positive cells  is  assigned  to  bone HERZENJ3ERG,  CHAN,  RAVITCH,  RIBLET,  AND  HERZENBERG  1319 
TABLE  IV 
Suppressor  Cells in Bone Marrow 
nos. of cells transferred  (X 10~) 
Spleen  Bone marrow 
Normal  Suppressed Normal  Suppressed 
Mean Ig-lb levels 
no. of  wk after transfer  mice 
1  2  3  4  6 
mg/ml 
12  8  0.2  >0.4  >0.4  >0.5  >0.3 
12  3  4  0.1  0.07  <0.02  <0.04  <0.04 
12  10  5  0.1  0.03  <0.02  --  -- 
12  10  4  0.3  0.4  >0.5  >0.5  >0.5 
12  1  4  0.07  0.4  0.4  0.3  0.1 
12  5  4  0.12  0.07  0.02  --  -- 
12  10  4  0.06  0.04  0.02  --  -- 
Donors of all cells were  (SJL  X  BALB/c)F1 mice 6-12  mo old.  Suppressed donors were 
exposed to maternal anti-Ig-lb perinatally. Ig-lb levels were determined by immunodiffusion. 
--  =  <0.01 mg of Ig-lb/ml. Recipients are BALB/c mice irradiated with 600  R  18 h  before 
transfer. 
marrow,  and  a  minimum estimate  of  30%  Thy-lb-positive cells  in Spleen, 
comparison of the dosage data for spleen  and bone marrow  (see  Table  IV) 
indicates a  minimum of twofold enrichment of suppressor cells or suppressor 
cell activity in the Thy-lb-positive cells in bone marrow. 
DISCUSSION 
In this and the preceding two publications (1,  2)  on chronic allotype sup- 
pression, we have established several points that may be briefly summarized 
as follows  ¢ 
(a) Production of Ig-lb immunoglobulin is suppressed in (SJL X  BALB/c)F1 
hybrids exposed early in life to antibody for the Ig-lb allotype. Most animals 
produce some Ig-lb and show complete suppression only after 6 mo of age. 
(b)  Suppression  is  an  active  process.  Lymphoid  tissues  from  chronically 
suppressed  animals suppress  Ig-lb  production when mixed with spleen  cells 
from normal  (never  exposed  to  anti-Ig-lb)  syngeneic animals, both  in vivo 
and in vitro. 
(c) Suppression is dependent on the presence of T  cells from the suppressed 
animal.  Elimination  of  T  cells  (Thy-lb-bearing  cells)  from  the  suppressor 
lymphoid tissue before mixture with the normal (target) spleen cells abrogates 
suppression. 
(d)  The effector T  cells  that suppress arise at an as yet undefined time in 
(SJL X  BALB/c)F1 hybrid animals treated with anti-Ig-lb before weaning. 
4 A more complete summary is presented in a recent review by L. A. Herzenberg and L. A. 
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TABLE  V 
Anti-Thy-lb (Theta) Sensitivity of Suppressor Cells in Bone Marrow 
no. of cells transferred  Mean Ig-lb level 
(X  106) 
no. 
Exp.  Spleen  Bone marrow  Treatment  of 
no.  mice 
Normal  Nor-  Sup- 
mal  pressed 
wk after transfer 
l  2  3  4  5  6  8 
II 
mg/ml 
12  --  4  0.2  >0.5  >0.5  >0.5  >0.5  >0.4  >0.5 
12  I0  --  4  0.4  >0.5  >0.5  >0.5  >0.5  >0.5  >0.5 
12  10  Anti-Thy-lb ~-  4  0.1  >0,5  >0.5  >0.4  >0,4  >0.4  >0.4 
C' 
12  10  NMS -1-  C p  4  0.07  0.1  <0.04  <0.02  --*  <0,02  <0.04 
10  --  4  0.07  0.04  ..... 
12  --  4  0.1  >0.5  >0.4  >0.5  >0.5  >0.5 
12  9  Anti-Thy lb q-  6  0.1  >0.5  >0.5  >0.5  >0,5  >0,5 
C' 
12  9  Congenic anti  6  0.3  >0.5  >0.5  >0.5  >0.5  >0.5 
Thy-lb +  C' 
12  9  NMS -}- C  p  4  0,1  0.1  0.2  0,2  0.05  0.05 
Donors of all cells were (SJL X BALB/c)Fz mice 6-12 mo old. Suppressed donors were exposed to maternal anti-Ig-lb 
perinatally. Where indicated under "Treatment," cell suspensions from suppressed donors were incubated with guinea 
pig serum and anti-Thy-lb or AKR normal serum, at 37°C for 45 rain, sedimented, washed, counted, mixed with syngeneic 
normal cells, and injected i.v. Ig-lb levels were estimated by immunodiffuslon. Recipients were BALB/c mice irradiated 
with 600 R  ~  18 h before transfer. In exp. I,  AKR anti-Thy lb or AKR normal serum was used. In exp.  II,  congenic 
anti-Thy-lb (from Dr. E. A. Boyse) was used in addition. 
* -- =  <0.01 rag of Ig-lb/ml serum. 
(e) These cells are readily demonstrated in spleen, lymph node, thymus, and 
bone marrow by transfer of these tissues from chronically suppressed animals, 
i.e., from animals, generally over the age of 6 mo, in which Ig-lb synthesis has 
either begun and terminated or never begun at all. 
(f) The suppressor cells survive indefinitely as a  population,  either by divi- 
sion  or recruitment.  They have been demonstrated  in  chronically suppressed 
animals over 18 mo of age and have been taken through at least two passages 
in irradiated hosts. 
From this summary it is clear that while studies to date clearly implicate a 
T  cell in  suppression of Ig-lb globulin  synthesis, its role in  the  process is far 
from understood. We have shown that the thymus, which contains few B cells, 
is as good a  source of suppressor activity as spleen; that T  cell-depleted sup- 
pressor spleen does not suppress although it is in the presence of an abundance 
of T  cells from the  concomitantly transferred normal  spleen  (target)  popula- 
tion; and that suppression is transferred by cells but not by serum. Thus, it is 
unlikely that the T  cells from suppressed animals are serving as cooperators for 
B  cells able to produce an antibody that is the suppressing agent. Exclusion of 
this hypothesis,  however,  leaves a  wide  range of possibilities in  which  the T 
cells from  suppressed  animals  are  directly  responsible  for  suppression  either 
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In an earlier publication  (2),  where we described the active suppression of 
immunoglobulin allotype synthesis,  we  discussed  the  pathway of differentia- 
tion of bone marrow-derived cells (B cells) from uncommitted precursor cells 
to immunoglobulin-producing cells committed to  the production  of a  unique 
immunoglobulin molecule of a  particular H  chain class and allotype. We con- 
cluded that for the specific suppression of Ig-lb synthesis to occur in a heter- 
ozygote, the  suppressing agent must recognize a  B  cell at some stage during 
differentiation when it is identifiable either as committed or able to be com- 
mitted to Ig-lb synthesis. This stage, we felt, probably occurs after the deci- 
sion to make Ig  b (as opposed to Ig  a) proteins has taken place, i.e., after allelic 
exclusion  has  taken  place.  The  generation  of  this  recognition  and  its  main- 
tenance in the T  cell line must in some way be related to the presence of anti- 
allotype serum in the young animal. Once established, however, it is apparently 
independent of the continued presence of the antiallotype. 
There is not sufficient evidence available,  as yet, to determine the mecha- 
nism by which the suppressor T  cells are generated or how they interact with 
the B  precursor cell  to  suppress Ig-lb synthesis.  It is possible that the  anti- 
allotype antibody removes Ig-lb precursors from the young animal for a suffi- 
cient period past the "tolerance" limit so that new Ig-lb precursors, when they 
appear, are no longer recognized as self and are then continually eliminated by 
T  cells acting in their normal surveillance role. While this hypothesis has much 
to recommend it in that it assigns a role to suppressor T  cells consistent with a 
known T  cell function, a number of accommodations must be made in order to 
explain the data. 
Why, for example, if we are dealing with a sensitized T  cell population able 
to reject Ig-lb precursors as a foreign graft, does Ig-lb synthesis become estab- 
lished in most animals before 6 mo of age and complete rejection only occur in 
animals over 6 mo of age? Similarly, why is a partially suppressed Ig-lb level 
frequently  maintained,  not  only in  young  animals,  but  often  for  the  life of 
those animals over 6 mo of age who do not become completely suppressed (1)? 
An alternate approach  to the mechanism of suppression is to focus on  the 
role of T  cells in the antigen-driven differentiation of B  cells from precursors 
to IgG antibody-producing cells  (14).  In general,  this differentiation requires 
interaction with a cooperating T  cell capable of recognizing either the antigen 
or a  carrier to which  the antigen has been attached  (15).  Therefore, response 
to an antigen may be limited not only by the number of B cell precursors able 
to differentiate to produce antibody to that antigen, but as well by the number 
of T  cells available to cooperate with the B cell precursors in order to facilitate 
their differentiation  to antibody-forming cells.  Put  another way, the require- 
ment  for  cooperation  with  T  cells  before  antibody  production  can  proceed 
creates a pressure point at which the extent of the antibody response may be 
controlled by the availability of cooperating T  cells. 
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i.e. a decrease of cooperators results in a decrease of the response, it is possible 
that another class of T cells exist that actively regulate the flow of B cells from 
precursors  to  antibody-forming cells.  The  data  we  have  presented  on  sup- 
pression of Ig-lb synthesis is as well explained by postulating that the T  cell 
responsible for the active suppression of Ig-lb is one of a group of many specific 
suppressor T  cells, collectively responsible perhaps for the active control of the 
levels of antibody in serum. 
A simple model for the mechanism of this kind of regulation could be compe- 
tition for B  cells between cooperators and suppressors, where blocking of the 
interaction between cooperators and B cell by suppressors results in prevention 
of further differentiation of the B  cell.  While under ordinary circumstances 
the presence of suppressors and cooperators adheres to a finely tuned balance, 
the presence of antiallotype serum in the young animals could shift this bal- 
ance  in  favor of overregulation of  Ig-lb  synthesis.  In  (SJL  X  BALB/c)F1 
animals, which like the SJL parent show an abnormal regulation of IgG immu- 
noglobulin synthesis, this early shift could result in  the establishment of an 
overdeveloped  population  of  regulator  (suppressor)  T  cells  that  specifically 
suppress Ig-lb precursors from differentiating to producers. 
Although this model in  many ways more  easily explains  the  partial  sup- 
pression of allotype synthesis frequently observed and certain other features 
of  the  "kinetics"  of  suppression,  e.g.,  temporary  release  from  suppression 
(1), it perhaps strains the imagination to postulate suppressor T  cells  for all 
classes and possibly all antibody specificities  that an animal can produce.  It 
will  remain for further study to decide which model, if either, more closely 
approximates the truth. 
Interestingly, there have been reports  recently of a  number of systems in 
which T  cells actively suppress antibody production (16-19)  although in these 
cases, T  cells have not been shown to selectively inhibit an immune response. 
The system described here offers the first example of suppressor T  cells with 
specificity. Just one of the two allotypes on just one of the classes  of IgG im- 
munoglobulins  in  heterozygotes  is  suppressed.  However,  the  generality  of 
this suppressive mechanism and its role  in regulation of antibody production 
is still an open question. The limitations of induction of active (T cell) allotype 
suppression  to  the  particular  genetic  background  of  (BALB/c  X  SJL)F1 
animals may be a clue that should be kept in mind in further genetic and cellu- 
lar immunologic explorations. 
SUMMARY 
Thymus-derived cells  (T cells)  that actively suppress production of IgG2a 
immunoglobulins carrying the Ig-lb allotype have been found in adult (SJL X 
BALB/c)F1 mice exposed to anti-Ig-lb early in life. The suppression is specific 
for Ig-lb. The allelic product, Ig-la, is unaffected. 
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suppress  production of Ig-lb by syngeneic spleen cells from normal  F1 mice. 
When a mixture of suppressed and normal cells is transferred into lethally ir- 
radiated  BALB/c mice, there is a short burst of Ig-lb production  after which 
Ig-lb levels in the recipient fall rapidly below detectability.  Pretreatment of 
the cells from the suppressed mice with antiserum specific for T  cells (anti-Thy- 
lb) plus complement before mixture destroys the suppressing activity. 
Similar results  with  suppressor cells were  obtained in  vitro using  Mishell- 
Dutton  cultures.  Mixture  of spleen cells from suppressed animals with sheep 
erythrocyte  (SRBC)-primed  syngeneic  normal  spleen  before  culture  sup- 
presses Ig-lb plaque-forming cell  (PFC)  formation while  leaving Ig-la PFC 
unaffected. Treatment of the suppressed spleen with anti-Thy-lb before trans- 
fer removes the suppressing activity. 
The authors wish to thank Doctors E. A. Boyse, Lloyd Old, and T. Takahashi for kindly 
supplying the congenic antiserum to Thy-lb. We also wish to thank Dr. Robert Mishell for 
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